L26/P-684 Impact of COMT rs4860 and CYP17A1 rs743572 genetic variants on the risk of premature ovarian insufficiency
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N. Khikmatillaeva und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does the COMT rs4860 (Val158Met) and CYP17A1 rs743572 polymorphisms affect the risk of premature ovarian insufficiency in reproductive-aged women? Summary answer Heterozygous genotypes of COMT rs4860 and CYP17A1 rs743572 were most frequent and significantly linked to premature ovarian insufficiency in reproductive-aged women. What is known already Premature ovarian insufficiency (POI) affects 0.5–1.0% of women of reproductive age and is characterized by amenorrhea, hypergonadotropic hypogonadism, and reduced estradiol levels. Genetic factors have been implicated in POI pathogenesis, with several polymorphisms in genes involved in steroidogenesis and estrogen metabolism, such as COMT and CYP17A1, suggested as potential contributors. Previous studies indicate that these genetic variants may influence ovarian function and hormonal regulation, but their exact role in POI development, particularly in specific populations, remains incompletely understood. Study design, size, duration This observational, uncontrolled case series included 24 reproductive-aged women (18–40 years) with clinically confirmed premature ovarian insufficiency. The study was conducted from January to May 2025. Participants/materials, setting, methods The study included 24 women aged 18–40 with clinically confirmed premature ovarian insufficiency (ESHRE/WHO criteria). Exclusion criteria were genetic syndromes, secondary POI, and severe somatic or endocrine diseases. Venous blood samples were collected for DNA extraction, and genotyping of COMT rs4860 and CYP17A1 rs743572 polymorphisms was performed using real-time PCR. Clinical histories, hormone levels, and ultrasound results were recorded. Main results and the role of chance Among the 24 women with premature ovarian insufficiency, analysis of COMT rs4860 (Val158Met) and CYP17A1 rs743572 polymorphisms revealed a predominance of the Met allele (COMT, 54.2%) and the A allele (CYP17A1, 62.5%). Heterozygous genotypes were most frequent: Val/Met for COMT and A/G for CYP17A1 (both 58.3%). Statistical analysis showed significant associations between these genetic variants and the presence of POI, suggesting a potential role in disease development. No significant deviations attributable to chance were observed, and allele and genotype distributions were consistent with Hardy–Weinberg equilibrium. These findings indicate that COMT and CYP17A1 polymorphisms may influence steroidogenesis and estrogen metabolism, contributing to the pathophysiology of POI in reproductive-aged women. Limitations, reasons for caution The study included a small, uncontrolled sample of 24 women, limiting generalizability. Findings require confirmation in larger, diverse cohorts. Functional studies are needed to clarify the mechanisms by which COMT and CYP17A1 variants contribute to premature ovarian insufficiency. Wider implications of the findings COMT and CYP17A1 variants may serve as genetic markers for early identification of women at risk of premature ovarian insufficiency, supporting personalized monitoring and preventive strategies in reproductive medicine. Trial registration number No
Zitieren
APA
Khikmatillaeva, N., Irgashev, D., & Mirzakhmedova, N. (2026). L26/P-684 Impact of COMT rs4860 and CYP17A1 rs743572 genetic variants on the risk of premature ovarian insufficiency. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1014
Vancouver
Khikmatillaeva N, Irgashev D, Mirzakhmedova N. L26/P-684 Impact of COMT rs4860 and CYP17A1 rs743572 genetic variants on the risk of premature ovarian insufficiency. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1014
BibTeX
@article{Khikmatillaeva2026,
author = {Khikmatillaeva, N. and Irgashev, D. and Mirzakhmedova, N.},
title = {L26/P-684 Impact of COMT rs4860 and CYP17A1 rs743572 genetic variants on the risk of premature ovarian insufficiency},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1014}
}
EUVIMED